MEDICAL CANNABIS

CULTIVATOR &  MANUFACTURER

ABOUT

Cilocybin was born out of the aspiration to transform people’s lives through creating access to products that work/medical cannabis. We are the first entity in South Africa to have both medical Cannabis Cultivation and Manufacturing licenses. We pride ourselves on being viewed as leaders in the medical cannabis space for our use of scientific research, innovation and commitment to reliable quality products that make a genuine impact on users. Our focus is primarily on the manufacturing of medical grade cannabis flower and final products and we are passionate about bringing products that adhere to the highest standards of quality, effectiveness, care and safety. Our indoor cultivation facility is GACP accredited and is current Good Manufacturing Practices (cGMP) compliant.

 

Cilo Cybin aims to combine Biotech and Pharmaceutical methodologies to deliver a holistic and individualised solution that empowers an individual to enhance health, performance and longevity through the use of technologies, apps, devices, supplementation and medication

PRODUCT & SERVICES

Good Manufacturing Services

We offer a wide range of contract manufacturing services to the cannabis industry under GMP.

Cultivation

We offer a wide range of products under our cultivation offering, ranging from supplying clones, to packaging flower for other cultivators.

Bulk API and Raw materials

We offer a wide range of GMP bulk products, such as crude, distillate and isolate cannabis products.

OUR JOURNEY

Inception of Cilo Cybin Pharmaceutical
Cilo Cybin Pharmaceutical was born in the heart of Gauteng, South Africa.
August
2018
Raising funding and License Application
During the first quarter of 2019, Cilo Cybin Pharmaceutical raised funding for the construction of a state of the art medical cannabis cultivation and manufacturing facility.
May
2019
Construction Started
Construction started towards the end of the second quarter of 2019.
June
2019
GACP approval
During the second quarter of 2020, Cilo Cybin Pharmaceutical received its Good Agricultural and Collection Practices(GACP) licence form the South African Health Products Regulatory Authority (SAHPRA) This allowed us to commence the cultivation of Medicinal Cannabis legally in South Africa for the global markets.
May
2020
cGMP Certification
During the Second quarter of 2021 we received our current Good Manufacturing Practices (cGMP) license to further process cannabis products. Under this license we are now allowed to manufacture, package and label final products, ready to be used by the end consumer.
July
2021
Announced an IPO
We announced and IPO on the Johannesburg Stock Exchange and aimed to raise funds from the public and institutions. Unfortunately it was not successful at the time
Nov
2022
Massive announcement
Watch this space...
April
2023